FABP3/H-FABP ELISA DY1678 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemFABP3/H-FABP ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY1678
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
Detection Range0.94 - 30 ng/mL
ReactivityHuman
Detection TargetFABP3/H-FABP
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Namefatty acid binding protein 3
NCBI Gene AliasesFABP11, H-FABP, M-FABP, MDGI, O-FABP

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 15 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot StudyJournal of clinical medicineAugust 11, 2025Ohnewein B, Shomanova Z, Jirak P, Paar V, Topf A, Pylypenko L, Schäbinger M, Volg F, Hoppe UC, Pistulli R, et al.Biomarker Analysis Serum concentrations of sST2 (DY523B-05), suPAR (DY807), GDF-15 (DY957) and H-FABP (DY1678) were measured by commercially available enzyme-linked immunosorbent assays (ELISAs), purchased from

(2) Newly Initiated Statin Treatment Is Associated with Decreased Plasma Coenzyme Q10 Level After Acute ST-Elevation Myocardial InfarctionInternational journal of molecular sciencesDecember 26, 2024Csengo E, Lorincz H, Csosz E, Guba A, Karai B, Toth J, Csiha S, Paragh G, Harangi M, Nagy GG.

(3) Novel Biomarkers as Potential Predictors of Decompensated Advanced Chronic Heart Failure-Single Center StudyJournal of clinical medicineNovember 14, 2024Fröhling T, Semo D, Mirna M, Paar V, Shomanova Z, Motloch LJ, Rukosujew A, Sindermann JR, Lichtenauer M, Pistulli R.research group. Those biomarkers were measured with commercially available ELISA kits (DuoSet ELISA DY1678, DY523B, DY807, DY957 and DFTA00, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s

(4) Myocardial transcriptomic analysis of diabetic patients with aortic stenosis: key role for mitochondrial calcium signalingCardiovascular diabetologyJuly 8, 2024Cherpaz M, Meugnier E, Seillier G, Pozzi M, Pierrard R, Leboube S, Farhat F, Vola M, Obadia JF, Amaz C, et al.

(5) Evaluation of New Cardiac Damage Biomarkers in Polytrauma: GDF-15, HFABP and uPAR for Predicting Patient OutcomesJournal of Clinical MedicineFebruary 8, 2024Aileen Ritter, Lorenz Lötterle, Jiaoyan Han, Miriam Kalbitz, Dirk Henrich, Ingo Marzi, Liudmila Leppik, Birte WeberSystemic concentrations of HFABP, GDF-15, and uPAR were measured in plasma samples using ELISA Kits (DY1678, DGD150, DUP00; R&D systems, Wiesbaden, Germany). Measurements were performed according to manufacturer’s

(6) Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective StudyJournal of clinical medicineOctober 23, 2023Cortés M, Lorenzo O, Lumpuy-Castillo J, Martínez-Albaladejo S, Taibo-Urquía M, Pello AM, Bollas AJ, Orejas M, Navas MÁ, Macia E, et al.(DANP00, Bio-Techne, Minneapolis, MN, USA), MMP-2 (MMP200, Bio-Techne, Minneapolis, MN, USA) and FABP3 (DY1678, Bio-Techne, Minneapolis, MN, USA). The technique was carried out following the manufacturer’s instructions.

(7) CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosisClinical Research in CardiologyOctober 1, 2023Elke Boxhammer, Joseph Kletzer, Jörg Kellermair, Bernhard Scharinger, Reinhard Kaufmann, Matthias Hammerer, Hermann Blessberger, Clemens Steinwender, Michael Lichtenauer, Klaus Hergan, et al.enzyme-linked immunosorbent assay (ELISA) kits (sST2: Duoset DY523, GDF-15: Duoset DY957, H-FABP: Duoset DY1678, IGF-BP2: Duoset DY674, suPAR: Duoset DY807, R&D Systems, USA). Manufactures’s instructions were performed

(8) Loss of fatty acid binding protein 3 ameliorates lipopolysaccharide-induced inflammation and endothelial dysfunctionThe Journal of biological chemistryMarch 1, 2023Nguyen HC, Bu S, Nikfarjam S, Rasheed B, Michels DCR, Singh A, Singh S, Marszal C, McGuire JJ, Feng Q, et al.analyzed as instructed by DuoSet ELISA Development System and Ancillary Reagent Kit 2 (R&D Systems, Cat. # DY1678 and DY008). ELISA for circulating FABP3 was performed following 4 h of i.p. injection of LPS (4 mg/kg)

(9) The Presence of Ascending Aortic Dilatation in Patients Undergoing Transcatheter Aortic Valve Replacement Is Negatively Correlated with the Presence of Diabetes Mellitus and Does Not Impair Post-Procedural OutcomesDiagnostics (Basel)January 18, 2023Elke Boxhammer, Stefan Hecht, Reinhard Kaufmann, Jürgen Kammler, Jörg Kellermair, Christian Reiter, Kaveh Akbari, Hermann Blessberger, Clemens Steinwender, Michael Lichtenauer, et al.suPAR were analyzed by using enzyme-linked immunosorbent assay (ELISA) kits (GDF-15: DY957, H-FABP: DY1678, IGF-BP2: DY674, suPAR: DY807, R&D Systems, Minneapolis, MN, USA). Manufactures’ instructions were performed

(10) A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15Journal of cardiovascular development and diseaseJanuary 5, 2023Kletzer J, Hecht S, Ramsauer S, Scharinger B, Kaufmann R, Kammler J, Kellermair J, Akbari K, Blessberger H, Steinwender C, et al.excluded in advance. Enzyme-linked immunosorbent assay (ELISA) kits (sST2: DY523, GDF-15: DY957, H-FABP: DY1678, IGF-BP2: DY674, suPAR: DY807, R&D Systems, Minneapolis, MN, USA) were used to quantify plasma levels

(11) CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?-A Multicentric Retrospective AnalysisJournal of personalized medicineSeptember 4, 2022Hecht S, Boxhammer E, Kaufmann R, Scharinger B, Reiter C, Kammler J, Kellermair J, Hammerer M, Blessberger H, Steinwender C, et al.enzyme-linked immunosorbent assay (ELISA) kits (sST2: Duoset DY523, GDF-15: Duoset DY957, H-FABP: Duoset DY1678, IGF-BP2: Duoset DY674 and suPAR: Duoset DY807; R&D Systems, Minneapolis, MN, USA). The mean value from

(12) Peri-event plasma PCSK9 and hsCRP after an acute myocardial infarction correlate with early deterioration of left ventricular ejection fraction: a cohort studyLipids in health and diseaseJuly 21, 2022Silva-Bermúdez LS, Vargas-Villanueva A, Sánchez-Vallejo CA, Palacio AC, Buitrago AF, Mendivil CO.

(13) Systolic Pulmonary Artery Pressure and Cardiovascular Biomarkers—New Non-Invasive Ways to Detect Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing TAVR?Reviews in Cardiovascular MedicineJune 24, 2022Elke Boxhammer, Clara Köller, Vera Paar, Dzeneta Fejzic, Richard Rezar, Christian Reiter, Jürgen Kammler, Jörg Kellermair, Matthias Hammerer, Hermann Blessberger, et al.by using enzyme-linked immunosorbent assay (ELISA) kits (sST2: Duoset DY523, GDF-15: DY957, H-FABP: DY1678, IGF-BP2: DY674, suPAR: DY807, R&D Systems, Minneapolis, MN, USA). Instructions of the manufactures

(14) Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection FractionCirculation: Heart FailureDecember 11, 2020Tarek Bekfani, Mohamed Bekhite Elsaied, Steffen Derlien, Jenny Nisser, Martin Westermann, Sandor Nietzsche, Ali Hamadanchi, Elisabeth FrÃ¶b, Julian Westphal, Daniela Haase, et al.receptor) were measured by using commercially available ELISA kits (GDF-15: DY957, suPAR: DY807, H-FABP: DY1678, R&D Systems). The exact description of this analysis is described in the Data Supplement. Skeletal Muscle

(15) Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and ControlsJournal of clinical medicineApril 15, 2020Jirak P, Pistulli R, Lichtenauer M, Wernly B, Paar V, Motloch LJ, Rezar R, Jung C, Hoppe UC, Schulze PC, et al.and H-FABP were measured using commercially available ELISA kits (DuoSet ELISA, DY523B, DY957, DY807, DY1678, and DFTA00, R&D Systems, Minneapolis, Minnesota, USA) in accordance with the instructions provided

(16) Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-StudyJournal of clinical medicineMarch 24, 2020Mirna M, Topf A, Wernly B, Rezar R, Paar V, Jung C, Salmhofer H, Kopp K, Hoppe UC, Schulze PC, et al.

(17) New Cardiovascular Biomarkers in Ischemic Heart Diseaseâ€”GDF-15, A Probable Predictor for Ejection FractionJournal of Clinical MedicineJune 27, 2019Daniel Dalos, Georg Spinka, Matthias Schneider, Bernhard Wernly, Vera Paar, Uta Hoppe, Brigitte Litschauer, Jeanette Strametz-Juranek, Michael Sponderutilizing enzyme-linked immunosorbent assay (ELISA) kits that are commercially available (Duoset DY206, DY1678, DY807, DY957; R&D Systems, Minneapolis, MN, USA). Preparation of all necessary reagents and measurements were

(18) Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failureActa Pharmacologica SinicaJuly 1, 2018Peter Jirak, Dzeneta Fejzic, Vera Paar, Bernhard Wernly, Rudin Pistulli, Ilonka Rohm, Christian Jung, Uta C Hoppe, P Christian Schulze, Michael Lichtenauer, et al.H-FABP were quantified using a commercially available ELISA kit (DuoSet ELISA, DY523B, DY957, DY807 and DY1678, R&D Systems, USA). ELISA assays were performed in accordance with the instructions supplied by the

(19) Propofol-based anaesthesia versus sevoflurane-based anaesthesia for living donor kidney transplantation: results of the VAPOR-1 randomized controlled trialBritish journal of anaesthesiaMay 1, 2017Nieuwenhuijs-Moeke GJ, Nieuwenhuijs VB, Seelen MAJ, Berger SP, van den Heuvel MC, Burgerhof JGM, Ottens PJ, Ploeg RJ, Leuvenink HGD, Struys MMRF.

Be the First to Write a Review!

FABP3/H-FABP ELISA

Human FABP3 DuoSet ELISA

FABP3/H-FABP ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (19)

Reviews

FABP3/H-FABP ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map